Early treatment with cinacalcet is more cost effective than delayed treatment for patients with hyperparathyroidism secondary to renal failure

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.529, 2007-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy

By Eandi Mario  

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 1041-1054

Adis International

Access to resources Recommend Favorite

Cinacalcet hydrochloride for the treatment of hyperparathyroidism

By Verheyen Nicolas   Pilz Stefan   Eller Kathrin   Kienreich Katharina   Fahrleitner-Pammer Astrid   Pieske Burkert   Ritz Eberhard   Tomaschitz Andreas  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 793-806

Informa Healthcare

Access to resources Recommend Favorite

Secondary Hyperparathyroidism in Children with Chronic Renal Failure: Pathogenesis and Treatment

By Sanchez C.P.  

Pediatric Drugs, Vol. 5, Iss. 11, 2003-01 ,pp. : 763-776

Adis International

Access to resources Recommend Favorite

Bilateral subthalamic deep brain stimulation (STN-DBS) is more cost effective than best medical treatment in patients with Parkinson's disease

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 524, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan

By Iseki Kunitoshi  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 601-610

Informa Healthcare

Access to resources Recommend Favorite